they are starting Phase 2 trials and if results hold up my bet is the FDA gives ProscaVax Fast Tract Approval
Gus
they are starting Phase 2 trials and if results hold up my bet is the FDA gives ProscaVax Fast Tract Approval
Gus
This is great news. Was this a clinical trial? trying to get a sense of the summary statistics of the patients.
Any idea when this will be approved?
Gus, Thanks for your continuing contributions. This one looks like it could be special.
Thanks Gus, gives me hope.
Of the 4 who didn't respond, i.e. they progressed, they don't say which ones were "hormone-naïve" or "hormone-independent recurrent" so it's possible all of the latter group didn't respond. It would have been nice if they broke it down, even through it's such a very tiny sample size (n=14).
Gus,
Thanks so much for sharing some good news on a potentially potent new weapon in the battle. Hopefully, they will fast track it and get quick FDA approval. And hopefully they will expand and stratify the phase 2 group to include a segment of hormone sensitive patients. Have a great day!
Mark
I can find no result for proscavax at the clinicaltrials.gov site. An internet search reveals company or public relations company websites only for this search and no honest medical sites about this "drug". Is there something missing?